Effect of miR-125a-5p expression on drug resistance and clinical prognosis of diffuse large B cell lymphoma

Han Ying,Yang Wen-xiu,Pu Zhen-hong,Wan Long

DOI: https://doi.org/10.3969/j.issn.1005-8982.2018.19.007

2018-01-01

Abstract:Objective To detect the expression of miR-125a-5p in the tissue of diffuse large B cell lymphoma (DLBCL), and to explore its effect on tumor drug resistance and prognosis. Methods DLBCL paraffin specimens and their clinical data were collected, and the patients were followed up to complete the survival data. qRT-PCR was used to detect the relative expression of miR-125a-5p mRNA. Immunohistochemical staining was used for detection of P-gp and Ki67 protein expressions in the tumor tissue. The correlation between miR-125a-5p and resistant protein P-gp expression was statistically analyzed, and the influence of miR-125a-5p expression level on DLBCL cell proliferation and the prognosis was explored. Results miR-125a-5p expression was significantly higher in DLBCL than the reactive hyperplasia group (P < 0.05); its expression quantity was related to LDH level and the immunophenotype of the patients, but not correlated with age, gender, primary site, clinical stage or IPI score (P >0.05). The positive expression rate of P-gp protein in the miR-125a-5p high-expression group was higher than that in the miR-125a-5p low-expression group. Kaplan-Meier and Log-rank survival analyses showed that the overall survival and recurrence-free survival of the patients with low expression of miR-125a-5p were higher than those of the high-expression group. COX risk proportion model analysis showed that Arbor stages Ⅲ and Ⅳ and miR-125a-5p high expression are the independent factors of poor prognosis of the patients with DLBCL. Conclusions The expression of miR-125a-5p is associated with the expression level of drug resistant protein P-gp in DLBCL. High expression of miR-125a-5p and Arbor stages Ⅲ and Ⅳ indicate poor prognosis of the patients with DLBCL. And miR-125a-5p can be used as a potential molecule for prediction of the prognosis of DLBCL.